Gregory A Otterson Selected Research

Colitis

10/2019

Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory A Otterson Research Topics

Disease

70	Neoplasms (Cancer) 02/2024 - 06/2002
50	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 08/2003
24	Lung Neoplasms (Lung Cancer) 02/2024 - 04/2003
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 03/2010
6	Diarrhea 02/2024 - 06/2002
6	Fatigue 02/2024 - 04/2006
6	Neutropenia 10/2016 - 04/2006
6	Leukemia 05/2015 - 05/2004
5	Pneumonia (Pneumonitis) 11/2023 - 11/2018
4	Nausea 02/2024 - 11/2010
4	Thrombocytopenia (Thrombopenia) 10/2016 - 09/2004
3	Melanoma (Melanoma, Malignant) 02/2024 - 01/2021
3	Vomiting 02/2024 - 11/2010
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2013
3	Adenocarcinoma 01/2018 - 01/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 06/2002
3	Malignant Mesothelioma 06/2012 - 05/2004
2	Cachexia 01/2022 - 04/2006
2	Exanthema (Rash) 01/2022 - 11/2010
2	Fanconi Anemia (Fanconi's Anemia) 01/2019 - 01/2016
2	Disease Progression 05/2018 - 03/2010
2	Brain Neoplasms (Brain Tumor) 02/2017 - 07/2016
2	Anemia 10/2016 - 11/2010
2	Dehydration (Water Stress) 10/2016 - 01/2010
2	Febrile Neutropenia 03/2016 - 11/2010
2	Hemorrhage 05/2015 - 06/2012
2	Sarcoma (Soft Tissue Sarcoma) 03/2014 - 02/2007
2	Hematologic Neoplasms (Hematological Malignancy) 08/2011 - 08/2009
2	Carcinogenesis 08/2009 - 11/2002
1	Skin Neoplasms (Skin Cancer) 02/2024
1	Mesothelioma 01/2024
1	Thrombocytosis (Thrombocythemia) 07/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2023
1	Hepatitis 05/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Heart Failure 01/2023
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023

Drug/Important Bio-Agent (IBA)

18	Immune Checkpoint InhibitorsIBA 11/2023 - 03/2015
11	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 04/2003
11	NivolumabIBA 01/2023 - 03/2015
9	Docetaxel (Taxotere)FDA Link 10/2019 - 06/2002
8	Biomarkers (Surrogate Marker)IBA 01/2020 - 06/2012
7	B7-H1 AntigenIBA 01/2023 - 11/2016
7	Carboplatin (JM8)FDA LinkGeneric 01/2019 - 08/2003
7	ErbB Receptors (EGF Receptor)IBA 11/2018 - 09/2014
7	Proteins (Proteins, Gene)FDA Link 11/2016 - 11/2004
5	IpilimumabIBA 01/2022 - 05/2018
5	Tyrosine Kinase InhibitorsIBA 01/2019 - 12/2010
5	Histone Deacetylase InhibitorsIBA 12/2017 - 05/2003
5	Bevacizumab (Avastin)FDA Link 11/2016 - 12/2010
5	Cisplatin (Platino)FDA LinkGeneric 05/2015 - 09/2004
5	Gemcitabine FDA Link 06/2013 - 09/2004
4	PlatinumIBA 01/2018 - 04/2010
4	Formaldehyde (Formol)FDA Link 09/2017 - 03/2013
4	Paclitaxel (Taxol)FDA LinkGeneric 03/2016 - 08/2003
4	SmokeIBA 09/2014 - 07/2009
4	Capecitabine (Xeloda)FDA Link 01/2013 - 06/2002
3	pembrolizumabIBA 07/2023 - 01/2020
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 05/2020
3	Messenger RNA (mRNA)IBA 01/2021 - 12/2013
3	Histones (Histone)IBA 01/2021 - 03/2006
3	CrizotinibIBA 01/2020 - 01/2013
3	AntibodiesIBA 01/2020 - 03/2013
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017 - 05/2011
3	Pemetrexed (MTA)FDA Link 11/2015 - 01/2013
3	ParaffinIBA 05/2014 - 03/2013
3	romidepsin (FK228)FDA Link 08/2011 - 05/2003
3	Suramin (Suramin Sodium)IBA 11/2010 - 08/2003
3	MicroRNAs (MicroRNA)IBA 07/2010 - 08/2009
2	binimetinibIBA 02/2024 - 01/2023
2	encorafenibIBA 02/2024 - 01/2023
2	Decitabine FDA Link 01/2023 - 06/2008
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2019
2	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 01/2021
2	AlbuminsIBA 01/2022 - 11/2015
2	130-nm albumin-bound paclitaxelIBA 01/2019 - 11/2015
2	rociletinibIBA 11/2018 - 10/2016
2	Vorinostat FDA Link 12/2017 - 05/2003
2	MethyltransferasesIBA 12/2017 - 05/2003
2	Phosphotransferases (Kinase)IBA 11/2016 - 06/2003
2	Angiogenesis InhibitorsIBA 11/2016 - 12/2010
2	Alanine Transaminase (SGPT)IBA 10/2016 - 06/2012
2	ElectrolytesIBA 03/2016 - 11/2010
2	Etoposide (VP 16)FDA LinkGeneric 05/2015 - 06/2003
2	Sunitinib (Sutent)FDA Link 05/2015 - 02/2014
2	3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA 06/2013 - 11/2012
2	Dasatinib (BMS 354825)FDA Link 04/2012 - 03/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2010 - 02/2007
2	EnzymesIBA 11/2009 - 06/2002
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2006 - 11/2004
2	Thymidine PhosphorylaseIBA 03/2005 - 06/2002
1	decitabine and cedazuridine drug combinationIBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Untranslated RNA (Noncoding RNA)IBA 01/2021
1	LigandsIBA 12/2020

Therapy/Procedure

35	Therapeutics 01/2024 - 04/2006
19	Drug Therapy (Chemotherapy) 07/2023 - 06/2002
9	Immunotherapy 07/2023 - 01/2017
6	Radiotherapy 11/2018 - 12/2014